{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:26:38Z","timestamp":1792661198998,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["496600"],"award-info":[{"award-number":["496600"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.nano.2010.10.002","type":"journal-article","created":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T04:28:46Z","timestamp":1288240126000},"page":"168-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine"],"prefix":"10.1016","volume":"7","author":[{"given":"Mehfuz","family":"Zaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Skwarczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl N.","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Batzloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2010.10.002_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/erv.09.160","article-title":"Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists","volume":"9","author":"Black","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2010.10.002_bb0010","first-page":"25","article-title":"Progress in M-protein-based subunit vaccines to prevent rheumatic fever and rheumatic heart disease","volume":"9","author":"Olive","year":"2007","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.nano.2010.10.002_bb0015","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(96)90797-7","article-title":"Group A streptococcus, pyoderma, and rheumatic fever","volume":"347","author":"Carapetis","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2010.10.002_bb0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5694\/j.1326-5377.1996.tb122012.x","article-title":"Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory","volume":"164","author":"Carapetis","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.nano.2010.10.002_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0950268898001952","article-title":"Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection","volume":"122","author":"Carapetis","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.nano.2010.10.002_bb0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(04)00975-2","article-title":"Acute rheumatic fever: a chink in the chain that links the heart to the throat?","volume":"4","author":"McDonald","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2010.10.002_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1099\/jmm.0.45555-0","article-title":"Dynamics of anti-M antibody response in a mouse model following intranasal infection with group A Streptococcus M-18","volume":"54","author":"Gladstone","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.nano.2010.10.002_bb0040","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1016\/j.vaccine.2008.08.037","article-title":"Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development","volume":"26","author":"Smeesters","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2010.10.002_bb0045","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1128\/IAI.69.6.4072-4078.2001","article-title":"Induction of autoimmune valvular heart disease by recombinant streptococcal m protein","volume":"69","author":"Quinn","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2010.10.002_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/138920307779941488","article-title":"T cell response in rheumatic fever: crossreactivity between streptococcal M protein peptides and heart tissue proteins","volume":"8","author":"Guilherme","year":"2007","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.nano.2010.10.002_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2005.01.007","article-title":"How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease","volume":"24","author":"Fa\u00e9","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.nano.2010.10.002_bb0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(94)92083-4","article-title":"Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci","volume":"344","author":"Pruksakorn","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2010.10.002_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2567.1996.d01-754.x","article-title":"Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci","volume":"89","author":"Brandt","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.nano.2010.10.002_bb0070","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0264-410X(97)00178-3","article-title":"Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci","volume":"15","author":"Brandt","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2010.10.002_bb0075","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/intimm\/6.8.1235","article-title":"Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci","volume":"6","author":"Pruksakorn","year":"1994","journal-title":"Int Immunol"},{"key":"10.1016\/j.nano.2010.10.002_bb0080","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/intimm\/9.11.1723","article-title":"Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus","volume":"9","author":"Hayman","year":"1997","journal-title":"Int Immunol"},{"key":"10.1016\/j.nano.2010.10.002_bb0085","first-page":"12","article-title":"Mapping a conserved conformational epitope from the M protein of group A streptococci","volume":"9","author":"Relf","year":"1996","journal-title":"Pept Res"},{"key":"10.1016\/j.nano.2010.10.002_bb0090","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.resmic.2004.12.009","article-title":"M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats","volume":"156","author":"Vohra","year":"2005","journal-title":"Res Microbiol"},{"key":"10.1016\/j.nano.2010.10.002_bb0095","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.vaccine.2007.01.079","article-title":"Comparative in silico analysis of two vaccine candidates for group A streptococcus predicts that they both may have similar safety profiles","volume":"25","author":"Shaila","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2010.10.002_bb0100","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/374800","article-title":"Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection","volume":"187","author":"Batzloff","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2010.10.002_bb0105","doi-asserted-by":"crossref","first-page":"e5147","DOI":"10.1371\/journal.pone.0005147","article-title":"Mechanism of protection induced by group A streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection","volume":"4","author":"Pandey","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2010.10.002_bb0110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.161.2.702","article-title":"Carrier-induced, hapten-specific suppression: a problem of antigen presentation?","volume":"161","author":"Renjifo","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2010.10.002_bb0115","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2010.10.002_bb0120","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nano.2010.10.002_bb0125","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.2174\/092986707782794069","article-title":"Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system","volume":"14","author":"Olive","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nano.2010.10.002_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/jm701091d","article-title":"Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group A streptococcal vaccine candidates","volume":"51","author":"Abdel-Aal","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2010.10.002_bb0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/74719","article-title":"New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population","volume":"6","author":"Brandt","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2010.10.002_bb0140","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/S0264-410X(02)00206-2","article-title":"Parenteral and mucosal delivery of a novel multi-epitope M protein-based group A streptococcal vaccine construct: investigation of immunogenicity in mice","volume":"20","author":"Dunn","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2010.10.002_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/505146","article-title":"Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization","volume":"194","author":"Batzloff","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2010.10.002_bb0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/erv.09.33","article-title":"Moving forward: a mucosal vaccine against group A streptococcus","volume":"8","author":"Georgousakis","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2010.10.002_bb0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(02)00318-3","article-title":"Lipopeptide vaccines\u2014yesterday, today, and tomorrow","volume":"2","author":"BenMohamed","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2010.10.002_bb0160","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.4049\/jimmunol.178.4.2370","article-title":"Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine\/granzyme B profiles","volume":"178","author":"Ranasinghe","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2010.10.002_bb0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(08)60974-5","article-title":"Indigenous health in Australia still lagging","volume":"372","author":"Pincock","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2010.10.002_bb0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nano.2006.04.007","article-title":"Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles","volume":"2","author":"Raman","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2010.10.002_bb0175","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1351\/pac200476091659","article-title":"From synthetic polyelectrolytes to polymer subunit vaccines","volume":"76","author":"Kabanov","year":"2004","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.nano.2010.10.002_bb0180","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/S0264-410X(00)00114-6","article-title":"Alkyl-polyacrylate esters are strong mucosal adjuvants","volume":"18","author":"Hilgers","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2010.10.002_bb0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-2427(98)00188-3","article-title":"Effect of various adjuvants on secondary immune response in chickens","volume":"66","author":"Hilgers","year":"1998","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.nano.2010.10.002_bb0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0939-6411(03)00093-6","article-title":"Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers","volume":"56","author":"Kusonwiriyawong","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2010.10.002_bb0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2174\/156720110791011846","article-title":"Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response","volume":"7","author":"Zaman","year":"2010","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.nano.2010.10.002_bb0200","doi-asserted-by":"crossref","first-page":"11360","DOI":"10.1021\/ja0645990","article-title":"Synthesis of 3-miktoarm stars and 1st generation mikto dendritic copolymers by \"living\" radical polymerization and \"click\" chemistry","volume":"128","author":"Whittaker","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2010.10.002_bb0205","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1002\/anie.201002221","article-title":"Novel self-adjuvanting vaccine delivery system: polyacrylate dendrimer nanoparticles","volume":"49","author":"Skwarczynski","year":"2010","journal-title":"Angew Chem Int Edn"},{"key":"10.1016\/j.nano.2010.10.002_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.nano.2010.10.002_bb0215","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2249.2002.01988.x","article-title":"Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice","volume":"130","author":"Aspord","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.nano.2010.10.002_bb0220","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.4049\/jimmunol.146.10.3583","article-title":"Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5. I. Effects of carrier, copolymer adjuvants, and lipopolysaccharide on isotype selection","volume":"146","author":"Kalish","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2010.10.002_bb0225","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nano.2010.10.002_bb0230","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/281492a0","article-title":"Complement-fixing IgG1 constitutes a new subclass of mouse IgG","volume":"281","author":"Ey","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.nano.2010.10.002_bb0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1440-1754.2002.00772.x","article-title":"Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors","volume":"38","author":"Steer","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.nano.2010.10.002_bb0240","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1128\/IAI.68.12.6587-6594.2000","article-title":"Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci","volume":"68","author":"Brandt","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2010.10.002_bb0245","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1371\/journal.pone.0000512","article-title":"Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach","volume":"2","author":"Amela","year":"2007","journal-title":"PLoS One"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963410003539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963410003539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:07:43Z","timestamp":1761548863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963410003539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1549963410003539"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2010.10.002","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2010.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}